{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:00:15Z","timestamp":1780707615689,"version":"3.54.1"},"reference-count":64,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,2,13]],"date-time":"2012-02-13T00:00:00Z","timestamp":1329091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Birth Defects Research"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Anniversaries of the identification of three human teratogens (i.e., rubella virus in 1941, thalidomide in 1961, and diethylstilbestrol in 1971) occurred in 2011. These experiences highlight the critical role that scientists with an interest in teratology play in the identification of teratogenic exposures as the basis for developing strategies for prevention of those exposures and the adverse outcomes associated with them. However, an equally important responsibility for teratologists is to evaluate whether medications and vaccines are safe for use during pregnancy so informed decisions about disease treatment and prevention during pregnancy can be made. Several recent studies have examined the safety of medications during pregnancy, including antiviral medications used to treat herpes simplex and zoster, proton pump inhibitors used to treat gastroesophageal reflux, and newer\u2010generation antiepileptic medications used to treat seizures and other conditions. Despite the large numbers of pregnant women included in these studies and the relatively reassuring results, the question of whether these medications are teratogens remains. In addition, certain vaccines are recommended during pregnancy to prevent infections in mothers and infants, but clinical trials to test these vaccines typically exclude pregnant women; thus, evaluation of their safety depends on observational studies. For pregnant women to receive optimal care, we need to define the data needed to determine whether a medication or vaccine is \u201csafe\u201d for use during pregnancy. In the absence of adequate, well\u2010controlled data, it will often be necessary to weigh the benefits of medications or vaccines with potential risks to the embryo or fetus. Birth Defects Research (Part A), 2012. \u00a9 Published 2012 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/bdra.22887","type":"journal-article","created":{"date-parts":[[2012,2,13]],"date-time":"2012-02-13T07:54:33Z","timestamp":1329119673000},"page":"123-128","source":"Crossref","is-referenced-by-count":21,"title":["Human teratogens update 2011: Can we ensure safety during pregnancy?"],"prefix":"10.1002","volume":"94","author":[{"given":"Sonja A.","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,2,13]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.30313"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2010.01942.x"},{"key":"e_1_2_3_4_1","unstructured":"California Department of Public Health.2011. Pertussis update June 15 2011.http:\/\/www.cdph.ca.gov\/programs\/immunize\/Documents\/PertussisReport2011\u201006\u201015.pdf. Accessed: October 30 2011."},{"key":"e_1_2_3_5_1","first-page":"279","article-title":"Elimination of rubella and congenital rubella syndrome\u2013United States, 1969\u20132004","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_3_6_1","first-page":"1128","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_3_7_1","first-page":"1424","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months \u2014 Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100448"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/15265161.2011.562595"},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.30308"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(99)00008-9"},{"key":"e_1_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181c52616"},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.2014"},{"key":"e_1_2_3_14_1","unstructured":"Food & Drug Administration (FDA).2012. Topamax (topiramate): Label change\u2010Risk for development of cleft lip and\/or cleft palate in newborns.http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm245777.htm. Accessed October 30 2012."},{"key":"e_1_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.11.024"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000176304"},{"key":"e_1_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1104409"},{"key":"e_1_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181d44752"},{"key":"e_1_2_3_19_1","first-page":"35","article-title":"Congenital cataract following German measles in the mother","volume":"3","author":"Gregg NM","year":"1941","journal-title":"Trans Ophthalmol Soc Aust"},{"key":"e_1_2_3_20_1","unstructured":"Hardy\u2010FairbanksAJ PanSJ JohnsonDR BernsteinHH.2010. Immune responses in infants following receipt of pertussis immunization by their mothers during pregnancy. Infectious Diseases Society of America Annual Meeting. Vancouver Canada; 2010."},{"key":"e_1_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1086\/421033"},{"key":"e_1_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq001"},{"key":"e_1_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.07.030"},{"key":"e_1_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197104222841604"},{"key":"e_1_2_3_25_1","first-page":"408","article-title":"Comparative safety of topiramate during pregnancy [abstract]","volume":"88","author":"Hernandez\u2010Diaz S","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"e_1_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000318293.28278.33"},{"key":"e_1_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61304-0"},{"key":"e_1_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181c225c0"},{"key":"e_1_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182329681"},{"key":"e_1_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2006.00484.x"},{"key":"e_1_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(62)92665-X"},{"key":"e_1_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182093814"},{"key":"e_1_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-011-0865-y"},{"key":"e_1_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(61)90927-8"},{"key":"e_1_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1214"},{"key":"e_1_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1009631"},{"key":"e_1_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.02.029"},{"key":"e_1_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.624"},{"key":"e_1_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ede.0000152903.55579.15"},{"key":"e_1_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.06.047"},{"key":"e_1_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.08.050"},{"key":"e_1_2_3_42_1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ajmg.c.30310","article-title":"Teratogenic exposures","volume":"157","author":"Obi\u010dan S","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"e_1_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1206"},{"key":"e_1_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002689"},{"key":"e_1_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60492-9"},{"key":"e_1_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.121459"},{"key":"e_1_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1401.070667"},{"key":"e_1_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2008.152900"},{"key":"e_1_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyn070"},{"key":"e_1_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1086\/505943"},{"key":"e_1_2_3_51_1","unstructured":"RobertsMD.2010. Qnexa (Phentermine\/Topiramate) presented at FDA's Endocrinologic and Metaboic DrugsAdvisory Committee Meeting Gaithersburg Maryland.http:\/\/www.fda.gov\/downloads\/advisorycommittees\/committeesmeetingmaterials\/drugs\/endocrino logicandmetabolicdrugsadvisorycommittee\/ucm227050.pdf. Accessed: October 30 2012."},{"issue":"6","key":"e_1_2_3_52_1","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.ajog.2011.01.047","article-title":"Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System","volume":"204","author":"Schatz M","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20236"},{"key":"e_1_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2010.09.005"},{"key":"e_1_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.11.958"},{"key":"e_1_2_3_56_1","first-page":"605","article-title":"Safety of tetanus toxoid in pregnant women: a hospital\u2010based case\u2010control study of congenital anomalies","volume":"73","author":"Silveira CM","year":"1995","journal-title":"Bull World Health Organ"},{"key":"e_1_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.479"},{"key":"e_1_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)74944-0"},{"key":"e_1_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.09.034"},{"key":"e_1_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2009.09.034"},{"key":"e_1_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090866"},{"key":"e_1_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000160915.93979.8f"},{"key":"e_1_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.3.487"},{"key":"e_1_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420380304"},{"key":"e_1_2_3_65_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708630"}],"container-title":["Birth Defects Research Part A: Clinical and Molecular Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbdra.22887","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bdra.22887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T12:57:16Z","timestamp":1700571436000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/bdra.22887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,13]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1002\/bdra.22887"],"URL":"https:\/\/doi.org\/10.1002\/bdra.22887","archive":["Portico"],"relation":{},"ISSN":["1542-0752","1542-0760"],"issn-type":[{"value":"1542-0752","type":"print"},{"value":"1542-0760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,13]]}}}